James R. Sulat, President & CEO at MEMORY PHARMACEUTICALS CORP (MEMY), bought 87,623 shares at $1.11 ($97K) on 2006-10-16, disclosed to the SEC on 2006-10-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |